Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem and Sleep Hygiene in Shoulder Arthroplasty Recovery
NCT03269760Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of zolpidem in sleep disorder (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Lead's Sleep scale. Started Sep 2017; status: completed.
02
Drugs
zolpidem
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT03269760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269760.